Next-generation stem cells—ushering in a new era of cell-based therapies

EA Kimbrel, R Lanza - Nature Reviews Drug Discovery, 2020 - nature.com
Naturally occurring stem cells isolated from humans have been used therapeutically for
decades. This has primarily involved the transplantation of primary cells such as …

Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases

YG Yuan, JL Wang, YX Zhang, L Li… - International Journal …, 2023 - Taylor & Francis
Exosomes are nanovesicles with a wide range of chemical compositions used in many
different applications. Mesenchymal stem cell-derived exosomes (MSCs-EXOs) are …

[HTML][HTML] Intranasally administered human MSC-derived extracellular vesicles inhibit NLRP3-p38/MAPK signaling after TBI and prevent chronic brain dysfunction

M Kodali, LN Madhu, RL Reger, B Milutinovic… - Brain, behavior, and …, 2023 - Elsevier
Traumatic brain injury (TBI) leads to lasting brain dysfunction with chronic
neuroinflammation typified by nucleotide-binding domain leucine-rich repeat and pyrin …

[HTML][HTML] Reprogramming reactive glia into interneurons reduces chronic seizure activity in a mouse model of mesial temporal lobe epilepsy

C Lentini, M d'Orange, N Marichal, MM Trottmann… - Cell stem cell, 2021 - cell.com
Reprogramming brain-resident glial cells into clinically relevant induced neurons (iNs) is an
emerging strategy toward replacing lost neurons and restoring lost brain functions. A …

Intranasally administered human MSC-derived extracellular vesicles pervasively incorporate into neurons and microglia in both intact and status epilepticus injured …

M Kodali, OW Castro, DK Kim, A Thomas… - International journal of …, 2019 - mdpi.com
Extracellular vesicles (EVs) derived from human bone marrow mesenchymal stem cells
(hMSCs) have great promise as biologics to treat neurological and neurodegenerative …

Neuroregenerative gene therapy to treat temporal lobe epilepsy in a rat model

J Zheng, T Li, S Qi, B Qin, J Yu, G Chen - Progress in neurobiology, 2022 - Elsevier
Temporal lobe epilepsy (TLE) is a common drug-resistant epilepsy associated with
abundant cell death in the hippocampus. Here, we develop a novel gene therapy-mediated …

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy

M Bershteyn, S Bröer, M Parekh, Y Maury, S Havlicek… - Cell Stem Cell, 2023 - cell.com
Mesial temporal lobe epilepsy (MTLE) is the most common focal epilepsy. One-third of
patients have drug-refractory seizures and are left with suboptimal therapeutic options such …

New trends and most promising therapeutic strategies for epilepsy treatment

A Riva, A Golda, G Balagura, E Amadori… - Frontiers in …, 2021 - frontiersin.org
Background: Despite the wide availability of novel anti-seizure medications (ASMs), 30% of
patients with epilepsy retain persistent seizures with a significant burden in comorbidity and …

Parvalbumin role in epilepsy and psychiatric comorbidities: from mechanism to intervention

LD Godoy, T Prizon, MT Rossignoli, JP Leite… - Frontiers in Integrative …, 2022 - frontiersin.org
Parvalbumin is a calcium-binding protein present in inhibitory interneurons that play an
essential role in regulating many physiological processes, such as intracellular signaling …

From progenitors to progeny: shaping striatal circuit development and function

R Knowles, N Dehorter, T Ellender - Journal of Neuroscience, 2021 - Soc Neuroscience
Understanding how neurons of the striatum are formed and integrate into complex synaptic
circuits is essential to provide insight into striatal function in health and disease. In this …